This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Ethnodyne. Active years: 2017-2023.
Company Filing History:

Years Active: 2017-2023
Title: Géraldine Le Goff: Innovator in Neurodegenerative Disorder Treatments
Introduction
Géraldine Le Goff is a prominent inventor based in Antony, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating neurodegenerative disorders. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Géraldine's latest patents include groundbreaking inventions. One patent focuses on "Compounds for treating neurodegenerative disorders," which relates to compounds of formula (I), their method of synthesis, and their application in treating such disorders. Another patent involves "4-vinyl-2-cyclopenten-1-one derivatives," detailing the production of these compounds and their use as antibiotic agents. This invention describes a compound of general formula (I) with specific substituents, including R1, R2, R3, and R4, which can be utilized in various therapeutic applications.
Career Highlights
Throughout her career, Géraldine has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Ethnodyne. Her experience in these institutions has allowed her to refine her research skills and contribute to significant advancements in her field.
Collaborations
Géraldine has collaborated with notable colleagues, including Jamal Ouazzani and Chérif Rabhi. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Géraldine Le Goff is a remarkable inventor whose work in neurodegenerative disorder treatments and antibiotic agents showcases her dedication to advancing medical science. Her contributions are vital in the ongoing quest for effective therapies.